Efficacy and safety of preoperative TACE in hepatocellular carcinoma beyond Milan criteria: A propensity score matching analysis
European Journal of Surgical Oncology · 2025
DOI: 10.1016/j.ejso.2025.110248 ↗Kurz gefasst
Fachartikel in der Zeitschrift European Journal of Surgical Oncology, 2025. Verfasst von Runhu Lan und 6 weiteren Autor:innen. Beteiligte Einrichtung: Department of Surgery, Institute of Hepato-Pancreato-Biliary Surgery, Hepatic Surgery Center, Tongji Hospital, Tongji Medical College, Huazhong Unive…. Hauptthemen laut MEDLINE: Chemoembolization, Therapeutic, Carcinoma, Hepatocellular, Liver Neoplasms, Hepatectomy. Die Arbeit nennt 32 Literaturangaben. Gefördert von: Huazhong University of Science and Technology, Huazhong University of Science and Technology Tongji Medical College.
Abstract (Originalsprache)
OBJECTIVES: To assess the impact of preoperative transarterial chemoembolization (TACE) on patients diagnosed with hepatocellular carcinoma (HCC) beyond the Milan criteria, and investigate the prognostic factors associated with long-term outcomes. MATERIALS & METHODS: From January 2013 to March 2018, 675 patients diagnosed with HCC beyond the Milan criteria, which were classified as Barcelona Clinic Liver Cancer (BCLC) stage A or B, were enrolled. Patients were assigned to two groups as follows: the surgery-alone group and the TACE + surgery group, to compare perioperative outcomes, overall survival (OS), and recurrence-free survival (RFS) following propensity score matching (PSM), a statistical method used to reduce selection bias. Univariable and multivariable Cox regression analyses were performed to identify the factors associated with OS and RFS. RESULTS: After PSM, 118 pairs of matched patients were selected. The postoperative 30-day morbidity (29.7 % vs. 27.1 %, p = 0.67) and length of hospital stay (12.0 days vs. 12.0 days, p = 0.90) were comparable between the two groups of patients. Patients in the TACE + surgery group demonstrated significantly improved median overall survival (median OS: 46.0 months vs. 29.5 months, p < 0.001) and median recurrence-free survival (median RFS: 24.0 months vs. 12.5 months, p < 0.001) compared with patients in the surgery-alone group. Multivariate Cox regression analysis revealed that preoperative TACE was an independent predictor of better overall survival (risk ratio [HR] 0.62, 95 % confidence interval [CI]: 0.47-0.82, p < 0.001) and recurrence-free survival (HR 0.47, 95 % CI: 0.36-0.61, p < 0.001). CONCLUSION: This study suggests that preoperative TACE is a safe procedure associated with improved OS and RFS for patients with HCC beyond the Milan criteria classified as BCLC stage A or B.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Surgery, Institute of Hepato-Pancreato-Biliary Surgery, Hepatic Surgery Center, Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, China.
- Division of Hepato-pancreato-biliary Surgery, Tianyou Hospital, Wuhan University of Science and Technology, Wuhan, China.
- Department of Surgery, Institute of Hepato-Pancreato-Biliary Surgery, Hepatic Surgery Center, Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, China. Electronic address: bhz…
Förderung
- Huazhong University of Science and Technology
- Huazhong University of Science and Technology Tongji Medical College
Zitieren
APA
Lan, R., He, Z., Wu, C., Yuan, X., Danzeng, A., Ciren, P., & Zhang, B. (2025). Efficacy and safety of preoperative TACE in hepatocellular carcinoma beyond Milan criteria: A propensity score matching analysis. European Journal of Surgical Oncology. https://doi.org/10.1016/j.ejso.2025.110248
Vancouver
Lan R, He Z, Wu C, Yuan X, Danzeng A, Ciren P, et al. Efficacy and safety of preoperative TACE in hepatocellular carcinoma beyond Milan criteria: A propensity score matching analysis. European Journal of Surgical Oncology. 2025. doi:10.1016/j.ejso.2025.110248
BibTeX
@article{Lan2025,
author = {Lan, Runhu and He, Zhengwei and Wu, Chengxian and Yuan, Xiaoyin and Danzeng, Awang and Ciren, Pingcuo and Zhang, Binhao},
title = {Efficacy and safety of preoperative TACE in hepatocellular carcinoma beyond Milan criteria: A propensity score matching analysis},
journal = {European Journal of Surgical Oncology},
year = {2025},
doi = {10.1016/j.ejso.2025.110248}
}
EUVIMED